C T Stier Selected Research

Hypertrophy

1/2000

Inhibition of NOS enhances pulmonary vascular changes in stroke-prone spontaneously hypertensive rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C T Stier Research Topics

Disease

3	Stroke (Strokes) 09/2001 - 01/2000
3	Hypertension (High Blood Pressure) 09/2001 - 10/2000
1	Cerebral Hemorrhage 09/2001
1	Heart Failure 09/2001
1	Vascular Diseases (Vascular Disease) 09/2001
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 09/2001
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2001
1	Thrombosis (Thrombus) 01/2001
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2001
1	Necrosis 10/2000
1	Proteinuria 10/2000
1	Body Weight (Weight, Body) 01/2000
1	Hypertrophy 01/2000

Drug/Important Bio-Agent (IBA)

2	AldosteroneIBA 09/2001 - 10/2000
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2000 - 01/2000
1	ifetrobanIBA 01/2001
1	arginine methyl esterIBA 10/2000
1	Angiotensin IIIBA 10/2000
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 10/2000
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2000
1	Nitroarginine (NG Nitro L Arginine)IBA 01/2000

Therapy/Procedure

1	Adrenalectomy 09/2001